Multifunctional upconversion nanocomposite for multi-purpose cancer theranostics
Source abstract
Abstract
In this work, we introduce the upconverting detection nanoprobes UCNP-TPP-GOx based on the upconversion quenching effect recovery for the ultrasensitive, expeditious, quantitative, and in vitro cellular detection of glucose. This nanoplatform consists of upconversion nanoparticles (UCNP), tetraphenyl porphyrin (TPP) and glucose oxidase (GOx). In a nutshell, UCNPs core are linked with cancer-killing TPP via condensation reaction to form UCNP-TPP, subsequently, UCNP-TPP-GOx is fabricated through glucose oxidase (GOx) decoration on the surface of the UCNP-TPP. Additionally, UCNP-TPP-GOx possesses characteristic photophysical property and it is highly suitable for optical detection. Furthermore, UCNP-TPP-GOx shows excellent selectivity toward glucose after only 3-min coincubation and the limit of detection (LOD) for the glucose is calculated as low as 0.86 μg mL−1. Moreover, the differentiation between cancer and normal cells through in vitro confocal imaging is achieved due to the large differences of glucose level in them. More importantly, the significant inhibition on carcinoma cell growth is realized by simply switching to the specific excitation wavelength, followed by the generation of toxic singlet oxygen from TPP moiety. Hence, the developed nanoprobes presenting new possibilities for on-site rapid glucose detection and concurrent theranostics in vitro in a “one stone two birds” strategy.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Luminescence and Fluorescent Materials · Advanced biosensing and bioanalysis techniques · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (41)
Show source-provided references
1. Lanthanide luminescence for functional materials and bio-sciences10.1039/B905604C ↗
2. Taking advantage of luminescent lanthanide ions10.1039/b406082m ↗
3. Benefiting from the unique properties of lanthanide ions10.1021/ar0400894 ↗
4. Current advances in lanthanide-doped upconversion nanostructures for detection and bioapplication10.1002/advs.201600029 ↗
5. Lanthanide-doped upconversion nanoparticles: emerging intelligent light-activated drug delivery systems10.1002/advs.201500437 ↗
6. Emerging biomaterials: Taking full advantage of the intrinsic properties of rare earth elements10.1016/j.nantod.2020.100952 ↗
7. Dual-Targeting Peptide-Guided Approach for Precision Delivery and Cancer Monitoring by Using a Safe Upconversion Nanoplatform10.1002/advs.202002919 ↗
8. Responsive upconversion nanoprobe for monitoring and inhibition of EBV-associated cancers via targeting EBNA110.1039/C8NR05015E ↗
9. Enhancing Hybrid Upconversion Nanosystems via Synergistic Effects of Moiety Engineered NIR Dyes10.1021/acs.nanolett.1c02391 ↗
10. Multiplexed detection of SARS-CoV-2 based on upconversion luminescence nanoprobe/MXene biosensing platform for COVID-19 point-of-care diagnostics10.1016/j.matdes.2022.111249 ↗
11. Rapid and ultrasensitive detection of SARS-CoV-2 spike protein based on upconversion luminescence biosensor for COVID-19 point-of-care diagnostics
12. Small Upconverting Fluorescent Nanoparticles for Biosensing and Bioimaging10.1002/adom.201600141 ↗
13. Glucose metabolic crosstalk and regulation in brain function and diseases10.1016/j.pneurobio.2021.102089 ↗
14. Biology of glucose metabolization in cancer cells
15. A comprehensive metabolic evaluation reveals impaired glucose metabolism and dyslipidemia in breast cancer patients early in the disease trajectory10.1016/j.clnu.2013.08.001 ↗
16. Loftfield · Cancer Prev. Res. · 2016 · 9 · 86610.1158/1940-6207.CAPR-16-0141 ↗
17. Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers10.1001/jama.294.22.2872 ↗
18. Evaluation of outcome prediction and disease extension by quantitative 2-deoxy-2-[18F] fluoro-D-glucose with positron emission tomography in patients with small cell lung cancer10.1007/s12149-011-0478-y ↗
19. Positron emission tomography with 2-deoxy-2-[18F]fluoro-D-glucose for evaluating local and distant disease in patients with cervical cancer10.1016/j.mibio.2003.12.004 ↗
20. Glucose signaling in the brain and periphery to memory10.1016/j.neubiorev.2019.03.018 ↗
21. Glucose dysregulation in Parkinson's disease: Too much glucose or not enough insulin?10.1016/j.parkreldis.2018.05.026 ↗
22. Advanced on-site glucose sensing platform based on a new architecture of free-standing hollow Cu(OH)2 nanotubes decorated with CoNi-LDH nanosheets on graphite screen-printed electrode10.1039/C9NR02720C ↗
23. Toward flexible surface-enhanced Raman scattering (SERS) sensors for point-of-care diagnostics10.1002/advs.201900925 ↗
24. A single nanowire sensor for intracellular glucose detection10.1039/C9NR01997A ↗
25. Enzyme-based glucose sensor: from invasive to wearable device10.1002/adhm.201701150 ↗
26. Peroxidase-Like Activity of Smart Nanomaterials and Their Advanced Application in Colorimetric Glucose Biosensors10.1002/smll.201900133 ↗
27. Glucose-Sensing Photonic Nanochain Probes with Color Change in Seconds10.1002/advs.202105239 ↗
28. Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel photosensitizers for selective photodynamic therapy10.1016/j.bmc.2005.02.025 ↗
29. A Highly Photostable Hyperbranched Polyglycerol-Based NIR Fluorescence Nanoplatform for Mitochondria-Specific Cell Imaging10.1002/adhm.201600212 ↗
30. Carbon quantum dots with intrinsic mitochondrial targeting ability for mitochondria-based theranostics10.1039/C7NR03658B ↗
31. Targeting mitochondria for cancer therapy10.1038/nrd3137 ↗
32. Inhibition of Mitochondrial Biosynthesis Using a “Right-Side-Out” Membrane-Camouflaged Micelle to Facilitate the Therapeutic Effects of Shikonin on Triple-Negative Breast Cancer10.1002/adhm.202200742 ↗
33. Efficacy dependence of photodynamic therapy mediated by upconversion nanoparticles: subcellular positioning and irradiation productivity10.1002/smll.201602053 ↗
34. Spatially Selective Monitoring of Subcellular Enzyme Dynamics in Response to Mitochondria-Targeted Photodynamic Therapy10.1002/anie.202203238 ↗
35. Specific generation of nitric oxide in mitochondria of cancer cell for selective oncotherapy10.1007/s12274-022-4166-0 ↗
36. Spectroscopic characterization and fluorescence imaging of Helicobacter pylori endogenous porphyrins10.1016/j.bpc.2017.05.010 ↗
37. MnO2-Nanosheet-Modified Upconversion Nanosystem for Sensitive Turn-On Fluorescence Detection of H2O2 and Glucose in Blood10.1021/acsami.5b02188 ↗
38. Fabrication of a LRET-based upconverting hybrid nanocomposite for turn-on sensing of H 2 O 2 and glucose10.1039/C6NR00470A ↗
39. Sensitive fluorescent detection of H2O2 and glucose in human serum based on inner filter effect of squaric acid-iron(III) on the fluorescence of upconversion nanoparticle10.1016/j.talanta.2016.10.008 ↗
40. A strategy for accurate detection of glucose in human serum and whole blood based on an upconversion nanoparticles-polydopamine nanosystem10.1007/s12274-017-1721-1 ↗
41. Smart Plasmonic Glucose Nanosensors as Generic Theranostic Agents for Targeting-Free Cancer Cell Screening and Killing10.1021/acs.analchem.5b01260 ↗